Weight loss medication was not commonly prescribed in this substance use disorder sample Prescription of these diabetes/weight-loss medications was relatively rare among those with alcohol or opioid use disorder based on clinical diagnosis present in their medical record (see Figure below)
Another area of uncertainty involves side effects, as users' perceptions of symptoms such as nausea or fatigue may vary widely and may even be interpreted as markers of treatment efficacy
Hence they stimulate the accumulation of lipid intermediate metabolites [lysophosphatidic acid (LPA), diacylglycerol (DAG), acylcarnitines and ceramides], which promote defects of the insulin signaling pathway, exacerbate IR and stimulate several signaling pathways related to inflammation and oxidative stress, creating a second vicious-cycle of a feed-forward effect [17, 2123]
Compelling results from the Phase 2B trial made headlines in December 2025, and now investors are waiting for additional data
Its long-lasting effects ensure continuous appetite and blood sugar regulation throughout the day